You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

GENESA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Genesa, and when can generic versions of Genesa launch?

Genesa is a drug marketed by Gensia Automedics and is included in one NDA.

The generic ingredient in GENESA is arbutamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the arbutamine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for GENESA?
  • What are the global sales for GENESA?
  • What is Average Wholesale Price for GENESA?
Summary for GENESA
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 11
Patent Applications: 249
DailyMed Link:GENESA at DailyMed
Drug patent expirations by year for GENESA

US Patents and Regulatory Information for GENESA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GENESA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 ⤷  Sign Up ⤷  Sign Up
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 ⤷  Sign Up ⤷  Sign Up
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for GENESA

See the table below for patents covering GENESA around the world.

Country Patent Number Title Estimated Expiration
Ireland 960742 ⤷  Sign Up
European Patent Office 0658538 La diagnose, l'évaluation et le traitement de la maladie de l'artère coronaire par simulation de l'exercice par l'utilisation de la livraison de boucle fermée des dragues d'un agent bêta agoniste qui simule l'exercice (Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist) ⤷  Sign Up
Germany 68928422 ⤷  Sign Up
Spain 2111973 ⤷  Sign Up
Austria 129644 ⤷  Sign Up
Ireland 71651 System for the closed-loop administration of an exercise simulating agent ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.